{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:59:37Z","timestamp":1772121577082,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.rmed.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:45:28Z","timestamp":1395103528000},"page":"729-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Understanding the GOLD 2011 Strategy as applied to a real-world COPD population"],"prefix":"10.1016","volume":"108","author":[{"given":"J\u00f8rgen","family":"Vestbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Vogelmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2014.03.002_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.03.002_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1465-9921-11-79","article-title":"Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations","volume":"11","author":"Glaab","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.rmed.2014.03.002_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1191\/1479972305cd079oa","article-title":"Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease","volume":"2","author":"Schlecht","year":"2005","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.rmed.2014.03.002_bib5","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD 2011). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2011 revision. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available at: http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2011_Jan21.pdf [last accessed 10.09.13]."},{"key":"10.1016\/j.rmed.2014.03.002_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-2600(12)70044-9","article-title":"GOLD 2011 disease severity classification in COPDGene: a prospective cohort study","volume":"1","author":"Han","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","article-title":"Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population","volume":"186","author":"Lange","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1183\/09031936.00195212","article-title":"Characteristics, stability and outcomes of the GOLD 2011 COPD groups in the eclipse cohort","volume":"42","author":"Agusti","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.03.002_bib9","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD 2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2013. Available at: http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2013_Feb20.pdf [last accessed 14.09.13]."},{"key":"10.1016\/j.rmed.2014.03.002_bib10","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD 2014). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. Available at: http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2014.pdf [last accessed 21.01.14]."},{"key":"10.1016\/j.rmed.2014.03.002_bib11","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD 2010)","year":"2010"},{"key":"10.1016\/j.rmed.2014.03.002_bib12","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1185\/03007990802457040","article-title":"Real-world physician and patient behaviour across countries: disease-specific programmes \u2013 a means to understand","volume":"24","author":"Anderson","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmed.2014.03.002_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD assessment test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.03.002_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.03.002_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.03.002_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1183\/09031936.00190908","article-title":"Inhaled corticosteroids in COPD: the case against","volume":"34","author":"Suissa","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.03.002_bib17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","article-title":"Tiotropium versus salmeterol for the prevention of exacerbations of COPD","volume":"364","author":"Vogelmeier","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/COPD.S24443","article-title":"Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease","volume":"6","author":"Franssen","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.rmed.2014.03.002_bib20","doi-asserted-by":"crossref","first-page":"w13053","DOI":"10.4414\/smw.2010.13053","article-title":"General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study","volume":"140","author":"Jochmann","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.rmed.2014.03.002_bib21","first-page":"89","article-title":"Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD","volume":"5","author":"Seaman","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.rmed.2014.03.002_bib22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1185\/03007995.2011.583230","article-title":"Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis","volume":"27","author":"Fitch","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmed.2014.03.002_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1183\/09031936.00121012","article-title":"Multicomponent indices to predict survival in COPD: the COllaborative COhorts to assess multicomponent indices of COPD in Spain-COCOMICS study","volume":"42","author":"Marin","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.03.002_bib24","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2213-2600(13)70016-X","article-title":"Authors' reply to: GOLD COPD categories are not fit for purpose in primary care","volume":"1","author":"Han","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2014.03.002_bib26","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2013.5732","article-title":"Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease","volume":"309","author":"Thomsen","year":"2013","journal-title":"J Am Med Assoc"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:29:38Z","timestamp":1760614178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611114001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0954611114001097"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2014.03.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718327686.793532737","asserted-by":"object"}]},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the GOLD 2011 Strategy as applied to a real-world COPD population","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}